Nyhetsarkiv for Brenk labben
We have received funding from the Olav Tjomslands Legat for funding for equipment and tools for the the crystallization lab.
Another paper from the Brenk group published.
Ludvik has joined the lab as PhD student in November. Welcome and good luck with your project!
The Nor-Openscreen application for this year's infrastructure call scored the highest possible marks in all categories! To quote from the reviewer comments: "This is an excellent proposal to enlarge and update existing infrastructure and services in chemical biology in Norway". Despite the very favorable evaluation, the proposal was not funded. This means, there will unfortunately be no new... Les mer
Our new paper on entangling selectivity determining features and on how to use this knowledge to design selective ligands has been published in J Med Chem!
Together with Nathalie Reuter and Bengt-Erik Haug from the Chemistry Department and Alexander Lundervold from the Høgskulen på Vestlandet (HVL) we got funding for the project «Towards better computational approaches and responsible innovation strategies in early drug discovery: application to antibiotics and COPD» under the Centre for Digital Life umbrella. In this project, we are aiming toward... Les mer
Our EXPLORE network application aiming at targeting the TPP riboswitch for hit discovery for new antibiotics will receive funding from JPI-AMR! Other partners in the network are Daniel Lafontaine (Université de Sherbrooke, Canada), Matthias Mack (Mannheim University of Applied Sciences, Germany), Petr Bartunek (CZ-OPENSCREEN, Czech Republic), Bengt Erik Haug (University of Bergen Norway) and... Les mer
A recording of Ruth's presentation of riboswitch ligand design at the Digital Life 2018 conference.
Our research about development of riboswitch ligands was chosen as partner project for Digital Life Norway.
About state-of the art of riboswitch ligand design and future perspectives.
A webinar about structure-based design of riboswitch and kinase ligands.
The Brenk lab will receive funding from NFR for developing future antibiotics acting via riboswitch binding. This project will fund two postdoc positions for three years, one in the lab of Bengt Erik Haug (Department of Chemistry) and one in the Brenk group. We are looking forward to continuing an exiting research project!
Sider
- juni 2025 (1)
- april 2025 (1)
- august 2024 (1)
- mai 2024 (1)
- februar 2024 (1)
- januar 2024 (1)
- juli 2023 (1)
- mars 2023 (1)
- desember 2022 (2)
- april 2022 (1)
- mars 2022 (1)
- august 2021 (1)
- juni 2021 (1)
- mai 2021 (1)
- januar 2021 (1)
- mars 2020 (2)
- februar 2020 (2)
- desember 2019 (1)
- september 2019 (1)
- august 2019 (1)
- desember 2018 (1)
- oktober 2018 (1)
- april 2018 (1)
- november 2017 (1)
- oktober 2017 (1)
- desember 2016 (2)
- september 2016 (1)
- mai 2016 (2)